Edition:
United Kingdom

People: ACADIA Pharmaceuticals Inc (ACAD.OQ)

ACAD.OQ on NASDAQ Stock Exchange Global Select Market

20.24USD
4:18pm BST
Change (% chg)

$0.07 (+0.35%)
Prev Close
$20.17
Open
$20.22
Day's High
$20.60
Day's Low
$20.00
Volume
289,644
Avg. Vol
872,375
52-wk High
$41.20
52-wk Low
$12.80

Young, Todd 

Mr. Todd Young is the Chief Financial Officer, Executive Vice President of the Company. Mr. Young joins ACADIA from Baxalta Incorporated, where he served as Senior Vice President and Treasurer and played an integral role as a business leader and in creating the initial capital structure of Baxalta. Baxalta was acquired by Shire in June 2016. Baxalta was formed in July 2015 when Baxter International Inc. spun-out its biopharmaceutical division. Prior to Baxalta, Mr. Young worked for over 14 years at Baxter holding multiple leadership roles, including Corporate Vice President and Treasurer, Vice President, International Finance, and Vice President, Global Financial Planning and Analysis (FP&A). Mr. Young’s global FP&A team was responsible for driving Baxter’s budgeting, forecasting, and long-range financial planning. As finance leader for Baxter’s international operations, he led a team of 900 finance members. Earlier in his career, Mr. Young practiced as a tax attorney at a major law firm. Mr. Young earned his Bachelor of Arts degree in Economics from Grinnell College and his J.D. from the University of Michigan School of Law.

Basic Compensation

Total Annual Compensation, USD 409,542
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 2,892,080
Fiscal Year Total, USD 3,301,620

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Stephen Biggar

352,326

Stephen Davis

15,158,100

Todd Young

3,301,620

Austin Kim

--

Srdjan Stankovic

7,196,470

Michael Yang

12,103,900
As Of  31 Dec 2017